Alpha1-adrenoceptors(α1-AR) and vascular smooth muscle cell growth

Prostate

Volumn 45, Issue SUPPL. 9, 2000, Pages 29-33

  Hoffman, Brian B ^a,b   Hu, Zhuo Wei ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Alpha1 adrenoceptors; Cell growth; Protein kinases; Smooth muscle cells

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; PROTEIN KINASE; RIBOSOME PROTEIN; S6 KINASE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; CELL GROWTH; CELL HYPERPLASIA; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFECT; GENE EXPRESSION; HUMAN; HYPERTROPHY; PRIORITY JOURNAL; PROTO ONCOGENE; SECOND MESSENGER; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; VASCULAR SMOOTH MUSCLE; CELL DIVISION; COMPARATIVE STUDY; CYTOLOGY; MALE; METABOLISM; PHYSIOLOGY; PROSTATE; REVIEW;

ADRENERGIC ALPHA-ANTAGONISTS; CELL DIVISION; HUMANS; MALE; MUSCLE, SMOOTH, VASCULAR; PROSTATE; PROTEIN KINASES; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 0033736062     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0045(2000)45:9+<29::AID-PROS7>3.0.CO;2-Z     Document Type: Article

References (42)

1. Basic FGF, EGF, and PDGF modify TGFbeta-induction of smooth muscle cell phenotype in human prostatic stromal cells
2. Prostate innervation
3. Identification, quantification, and localization of mRNA for three distinct alpha 1 adrenergic receptor subtypes in human prostate
4. Prostatic adrenoceptors
5. Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia
6. New perspectives in hypertension research. Potentials of vascular biology
7. Angiotensin II and the control of cardiovascular structure
8. Vascular remodeling: Mechanisms and implications
9. Smooth muscle growth factors
10. Growth-stimulating effect of catecholamines on rat aortic smooth muscle cells in culture
11. α1-Adrenergic stimulation and β2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells
12. Regulation of vascular smooth muscle growth by alpha 1-adrenoreceptor subtypes in vitro and in situ
13. Alpha1D-adrenergic receptors and mitogen activated protein kinase mediate increased protein synthesis by arterial smooth muscle
14. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells
15. α1-Adrenergic stimulation of platelet-derived growth factor A-chain gene expression in rat aorta
16. α1 Adrenergic receptor-induced c-fos gene expression in rat aorta and cultured vascular smooth muscle cells
17. Fos/jun repression of cardiac-specific transcription in quiescent and growth-stimulated myocytes is targeted at a tissue-specific cis element
18. The cardiac beta-myosin heavy chain isogene is induced selectively in alpha 1-adrenergic receptor-stimulated hypertrophy of cultured rat heart myocytes
19. Adrenergic regulation of the skeletal alpha-actin gene promoter during myocardial cell hypertrophy
20. The alpha1A-adrenergic receptor mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy
21. Gq and Ras-dependent pathways mediate hypertrophy of neonatal rat ventricular myocytes following alpha1-adrenergic stimulation
22. Differential activation of protein kinase C isoforms by endothelin and phenylephrine and subsequent stimulation of p42 and p44 mitogen-activated protein kinases in ventricular myocytes cultured from neonatal rat hearts
23. The tyrosine kinase inhibitor, genistein, prevents alpha-adrenergic-induced cardiac muscle cell hypertrophy by inhibiting activation of the Ras-MAP kinase signaling pathway
24. Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy
25. Enhanced Galphaq signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure
26. Gq signaling in cardiac adaptation and maladaptation
27. The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-associated protein kinase cascades
28. Role of extracellular signal-regulated kinases in angiotensin II-stimulated contraction of smooth muscle cells from human resistance arteries
29. G protein-coupled receptors and signaling pathways regulating growth responses
30. 1-adrenergic receptor stimulation of mitogenesis in human vascular smooth muscle cells: Role of tyrosine protein kinases and calcium in activation of mitogen-activated protein kinase
31. α1 Adrenergic receptors activate phosphatidylinositol 3-kinase in human vascular smooth muscle cells: Role in mitogenesis
32. 2+ or protein kinase C in alpha-1A adrenergic receptor activation of mitogen-activated protein kinase pathways in transfected PC12 cells
33. Coupling efficiencies of human alpha 1-adrenergic receptor subtypes: Titration of receptor density and responsiveness with inducible and repressible expression vectors
34. Contrasting signaling pathways of alpha1A and alpha1B adrenergic receptor subtype-activation of PI 3-kinase and Ras in transfected NIH3T3 cells
35. Regulation of Ras-mediated signaling: More than one way to skin a cat
36. Parallel signal processing among mammalian MAPKs
37. 1 adrenergic receptors
38. Phospholipid kinases
39. Sequestration of a G-protein beta gamma sub-unit or ADP-ribosylation of Rho can inhibit thrombin-induced activation of platelet phosphoinositide 3-kinases
40. Positive regulation of the nuclear activator CREM by the mitogen-induced p70 S6 kinase
41. Rapamycin inhibition of interleukin-2-dependent p33cdk2 and p34cdc2 kinase activation in T lymphocytes
42. An intracellular calcium signal activates p70 but not p90 ribosomal S6 kinase in liver epithelial cells